Clinical trial
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable…
NCT00415298 · University of California, San Diego, Other · Unknown status
Key facts
| NCT number | NCT00415298 |
|---|---|
| Title | AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer |
| Official title | AP5346 for Recurrent/Unresectable Squamous Cell Carcinoma of the Head and Neck: A Pilot Study With Clinical and Biological Endpoints |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | DACH polymer platinate AP5346, oxaliplatin, gene expression analysis, immunohistochemistry staining method, pharmacological study, biopsy |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| First posted | Dec 22, 2006 |
| Last update posted | Jan 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: